These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 213358)

  • 1. [Cervix carcinoma as an immunological model. Part 2. In vitro studies and HLA system typing].
    Koenig UD
    Fortschr Med; 1978 Sep; 96(34):1727-30. PubMed ID: 213358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cervix carcinoma as a tumor immunologic model. 1. Morphological and seroepidemiological studies].
    Koenig UD
    Fortschr Med; 1978 Sep; 96(33):1679-83. PubMed ID: 212355
    [No Abstract]   [Full Text] [Related]  

  • 3. [HL-A polymorphism and its relation to cervix neoplasms].
    Koenig UD; Müller N
    Fortschr Med; 1977 Mar; 95(9):565-8. PubMed ID: 844783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
    Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
    J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients (author's transl)].
    Dostal V; Mayr WR
    Osterr Z Onkol; 1977; 3(5-6):119-21. PubMed ID: 193077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
    Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
    Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma.
    van Driel WJ; Tjiong MY; Hilders CG; Trimbos BJ; Fleuren GJ
    Gynecol Oncol; 1996 Jul; 62(1):33-41. PubMed ID: 8690288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
    Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
    Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation (author's transl)].
    Palencia C; Wicke L; Kärcher KH; Gitsch E; Hernuss P; Steffen C
    Wien Klin Wochenschr; 1976 Aug; 88(15):495-501. PubMed ID: 997530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human mammary carcinoma. A model for the relationship between tumor proliferation, tumor-associate macrophages, and prognostic factors].
    Müller H
    Veroff Pathol; 1992; 138():1-235. PubMed ID: 1323168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer.
    Aurelian L; Strnad BC
    Cancer Res; 1976 Feb; 36(2 pt 2):810-20. PubMed ID: 175945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
    Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant therapeutic vaccines against cancer of the uterine cervix].
    Berumen J; Villegas N
    Salud Publica Mex; 1997; 39(4):288-97. PubMed ID: 9381250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the correlation between immune responses and histopathological changes of primary lesion in patients with cervical cancer following radiation therapy (author's transl)].
    Shiozawa I
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1986-94. PubMed ID: 7211216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.